chemical results indicate that the quantity of Cu(II) being reduced to Cu(I), especially within the aqueous phase, is increased within the first 48 hours of experimentation
perform best. These two methods were used for a genome scan of the HapMap Phase II database. Based on these results, we carried out an enrichment analysis to uncover signals
InAs waveguide sandwiched between a p-InAs0.61Sb0.13P0.26 lower cladding layer grown by liquid phase epitaxy and an n+ -InAs plasmonic upper cladding layer grown by MBE. The laser peak ... InSb QD layer), which is close…
dashes were obtained on InAs(001) substrate by combine technology based on liquid-phase epitaxy (LPE) and metalorganic vapour epitaxy (MOVPE) methods. Bimodal distribution in a size of the InSb ... reverse) and…
variety of applications including gas sensing, optical spectroscopy, bio-medical diagnostics etc. Although type II InSb/InAs QDs have shown electroluminescence up to room temperature and are a promising candidate…
platin resistant OC (R-OC). Pemetrexed (AlimtaTM, PMX), a multitarget drug, is in clinical phase II for the treatment of R-OC. Ourresearch group has recently developed a new class ... whoseexpression could be…
enable successful go/no-go decision for further development and thereby helping to minimize phase II attrition. Surrogate end points, in addition to tumor markers, add more confidence to overall ... patient enrichment…
proceeding from the assays made. Individuals, selected at the first stage, undergo the second phase of the survey, which uses a panel of phenotypic biomarkers. Etiopathogenesis of autoimmune diseases ... chronic…
Along the last years, monolithic porous polymers have been widely investigated as stationary phases for separation techniques. Advantages are ease of preparation, high permeability and a vast variety of easily…
platin resistant OC (R-OC). Pemetrexed (AlimtaTM, PMX), a multitarget drug, is in clinical phase II for the treatment of R-OC. Our research group has recently developed ... expression could be informative of the effect…
against hepatitis C virus demonstrated promise in preliminary human safety trials, and a larger phase II clinical trials are under consideration to further determine the efficacy of the vaccine. This
nutrition i.e., standard energy and protein (plane I), low energy, low protein (plane II), high energy and high protein (plane III) were designed for allotment of two groups in each ... sporozoite. Feed intake and N…
alumina composite based on high capacity adsorbent using a leaf as a template and ii) the issue of handling spent regenerant resulting from regeneration of such high capacity adsorbents ... template and alum as a source…
immunogenic in human and it is already passed successfully clinical trials phase III and phase II respectively. Moreover, FSH long acting was approved by the European Commission (EC) for treatment ... toxic in monkeys…
found that GTF of the chosen isolate (H5) was produced during the middle stationary phase (18-35 hours) and its maximal productivity was reached at 22 hours. Purification ... with specific activity 2.4 U/ml. Two…
conventional chemotherapeutic drug combowhile alleviatingthe associated drug-induced toxicity. Its mechanism of action involved phase-specific cell cycle arrest and exhibited anticarcinogenic activity in 8 different…
marianensis has an anti-Gram (+) activity which could not be bound to reverse phase column; (ii) bacteria, oomycete and fungal target. Bicornutin A does not have antimicrobial activity but play
cancer. A second ErbB2-antibody targeted immunoliposomal doxorubicin is being studied in a pivotal Phase II trial in ErbB2-overexpressing breast cancer patients. The development of these and similar drugs
more efficacies could be kept by clinical studies after FDA’s approval. The phase ÐÂ?II clinical trials include big number of subjects and need high cost in comparison
CENTRAL databases were searched for articles published until October 2014. Eligible studies were randomized phase II and III trials comparing anti-EGFR MoAbs containing regimens with the same regimens without
indication for benefi cial eff ects on sleep maintenance. In a Phase-II study in insomnia patients, piromelatine demonstrated signifi cant improvements in sleep maintenance based on objective assessments (polysomnography
methods but this challenge was overcome by the on-line methods. Combination of solid phase extraction (SPE) with high performance liquid chromatography allows direct analysis of small molecules (i.e., drugs ... sample…
very beneficial in the future. Consequently, the paradigms of drug development (efficacy criteria for phase II, for instance) as well as the regulatory and registration requirements will further evolve. Such
mitigate these issues by delaying the decline in NCF. RTOG 0933 is a phase II clinical trial aimed at HA-WBRT for patients with metastatic brain lesions. Published results from
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.